September 27, 2012
Major cancer protein amplifies global gene expression, NIH study finds
Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at the National Institutes of Health and colleagues found that, unlike many other cell growth regulators, MYC does not turn genes on or off, but instead boosts the expression of genes that are already turned on.
September 13, 2012
No significant difference in asthma control across three approaches to adjust medication dose in mild asthma
A study comparing three common approaches to periodically adjust the dosage of inhaled corticosteroids (ICS) for people with mild asthma has found no detectable differences in how often a person’s asthma worsened. The methods examined in this study were a patient-guided modification based on symptoms, an assessment made by an examining physician, or the results of a breath test to measure inflammation.
September 27, 2012
: NIH Record
NIH scientists receive 2012 Service to America Medals
Dr. Neal Young, chief of NHLBI's Hematology Branch, received the Sammie in the Science and Environment category.
September 25, 2012
: Boston Children's Hospital
First-ever treatment for rare childhood aging disease shows improvement in all trial participants
Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal “rapid-aging” disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer.
Reducing the Burden of Sickle Cell Disease
Meeting 26-year old Tiffany McCoy, a bubbly and happy mother, you would never know that she has a serious disease. She is one of about 100,000 Americans with sickle cell disease. Read full story of success...
International program expands efforts to improve blood transfusion safety
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has launched an $87.2 million international research program to extend a highly successful program assessing blood banking and transfusion medicine. Research conducted under the seven-year program will focus on improving transfusion benefits and reducing its risks Read full fact sheet...